TDOC — Teladoc Health, Inc. stock price, charts and financials

QT60Teladoc Health, Inc.

Teladoc Health, Inc. (NYSE: TDOC) is a Healthcare company in the Medical - Healthcare Information Services industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
6.71
+0.03+0.45%
OverviewShort InterestFilings
TDOCQT60Teladoc Health, Inc.·NYSE
6.71+0.45%
TA
Loading chart...
Signal & projected range
Earnings big beat — drift (PEAD)Historical pattern — not a prediction
Recent priceDays this stock last showed the setupRange of past outcomes (±1σ)
Horizon
0%Past 3 monthsToday
Unlock the projected rangeSee where this setup landed historically — with Premium.
Unlock with Premium

Over the next 20 trading days, similar setups historically landed in a measured range of outcomes. Unlock with Premium to see the median return, the typical range, and how often they were positive. This is the historical range of outcomes — not a prediction of this stock’s price.

Ranges describe how this exact setup resolved in the past — derived from thousands of historical occurrences across QuoTrend’s coverage since 2006, survivorship-corrected to include companies that later delisted. The band is the typical spread (±1σ) of those outcomes, not a forecast; the central value is their average move. Fewer matching cases over longer horizons widen the band and lower its reliability. Backtested results are hypothetical, based on historical data, and do not represent actual trading. Past performance does not guarantee or predict future results. QuoTrend is an educational research tool, not investment advice. Markets involve risk, including loss of principal.

Screen all →
OMDA-1.61%$20.18CERT-4.65%$7.80GDRX+5.70%$3.34HSTM+5.19%$29.80WGS+4.48%$70.90PHR+1.24%$11.44HTFL+1.94%$27.28PGNY-0.16%$31.48
Snapshot
Index-P/E-EPS (ttm)-0.99Insider Own1.38%Shs Outstand180.51MPerf Week-25.03%
Market Cap1.21BForward P/E-EPS next Y-0.62Insider Trans-6.81%Shs Float180.47MPerf Month-27.39%
Enterprise Value1.46BPEG-EPS next Q-0.17Inst Own-Short Float15.55%Perf Quarter3.41%
Income-178.00MP/S0.48EPS this Y12.58%Inst Trans-Short Ratio5.87Perf Half Y22.57%
Sales2.49BP/B0.92EPS next Y28.84%ROA-6.43%Short Interest28.06MPerf YTD-4.57%
Book/sh7.26P/C1.56EPS next 5Y-ROE-13.08%52W High9.93 -32.46%Perf Year-7.35%
Cash/sh4.29P/FCF5.39EPS past 3/5Y-ROIC-7.11%52W Low4.42 51.82%Perf 3Y-76.11%
Dividend Est.-EV/EBITDA-Sales past 3/5Y1.68% 18.26%Gross Margin73.53%Volatility6.99% 5.10%Perf 5Y-95.54%
Dividend TTM-EV/Sales0.59EPS Y/Y TTM83.13%Oper. Margin-6.98%ATR (14)0.57Perf 10Y-62.17%
Dividend Ex-Date-Quick Ratio0.81Sales Y/Y TTM-3.15%Profit Margin-7.13%RSI (14)32.33Recom2.64
Dividend Gr. 3/5Y-Current Ratio0.83EPS Q/Q-10.53%SMA20-24.84%Beta2.09Target Price8.25
Payout0.00%Debt/Eq0.75Sales Q/Q-3.96%SMA50-17.86%Rel Volume1.46Prev Close6.68
Employees5,600LT Debt/Eq0.74EarningsOct 28SMA200-2.90%Avg Volume4.99MPrice6.71
IPO DateJun 30, 2015Option/ShortYes / YesEPS/Sales Surpr.15.92% -1.38%Net Debt/EBITDA-3.60Volume7,269,649Change0.45%
Analyst Ratings
DateActionAnalystRatingTarget
Jul-30-26ReiteratedJefferiesHold$9.00 → $8.00
Jul-30-26ReiteratedEvercore ISI GroupIn Line$6.00 → $7.50
Jul-21-26ReiteratedCanaccord GenuityBuy$11
Apr-08-26ReiteratedEvercore ISI GroupIn Line$9.00 → $6.00
Mar-10-26UpgradeDeutsche BankHold → Buy$18 → $11
Feb-26-26ReiteratedStifel NicolausHold$8.00 → $6.00
Feb-26-26ReiteratedWells FargoEqual Weight$6.00
Jan-16-26ReiteratedGoldman SachsBuy$9.00 → $8.00
Jan-09-26ReiteratedGoldman SachsBuy$10 → $9.00
Dec-08-25InitiatedBarclaysEqual Weight$20 → $8.50
Latest News
Aug-04-26
Aug-04-2611:00AM
TDOC Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Teladoc Health (TDOC)gurufocus.com
Aug-03-26
Aug-03-2604:30PM
Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directorsglobenewswire.com
10:41AM
Are Investors Undervaluing Teladoc Health (TDOC) Right Now?zacks.com
10:07AM
TDOC SHAREHOLDER INVESTIGATION: SueWallSt Notifies Investors of Potential Securities Claims Involving Teladoc Healthprnewswire.com
Jul-31-26
Jul-31-2604:58PM
Teladoc Health Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Teladoc Health (TDOC)prnewswire.com
Jul-30-26
Jul-30-2607:00PM
Here are the top movers in Thursday's session.ChartMill
01:35PM
Teladoc Health Q2 Earnings Beat Estimates on Integrated Care Strengthzacks.com
10:09AM
Teladoc Stock Plummets on Revenue Miss, Lowered Outlookschaeffersresearch.com
09:00AM
Why Teladoc Health Stock Is Dropping Thursday Following Soft Q3 Outlookbenzinga.com
08:04AM
Teladoc Health Q2 Earnings Call Highlightsmarketbeat.com
07:21AM
Teladoc tumbles on revenue forecast cut as BetterHelp demand shifts hurtreuters.com
02:03AM
Teladoc Health, Inc. (TDOC) Q2 2026 Earnings Call Transcriptseekingalpha.com
Jul-29-26
Jul-29-2608:31PM
Teladoc (TDOC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimateszacks.com
07:26PM
Teladoc (TDOC) Reports Q2 Loss, Lags Revenue Estimateszacks.com
05:00PM
Why Teladoc Stock is Getting Crushed Wednesday After Hoursbenzinga.com
Company

Teladoc Health, Inc. offers remote medical services to individuals both domestically in the United States and internationally. Their extensive range of solutions covers a wide array of health needs, from routine and acute conditions to complex and long-term illnesses such as diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and various mental health issues. The company delivers numerous programs, including virtual primary and specialized medical care, management for chronic diseases, expert second opinion services, mental wellness support, and core platform and service offerings. They serve a diverse client base, including corporations, health insurance providers, hospitals and healthcare systems, financial service companies, and individual patients. The Teladoc, Livongo, and BetterHelp brands fall under their purview. Founded in 2002, the company, which operated as Teladoc, Inc. until its renaming in August 2018, is based in Purchase, New York.

Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue2,4892,5302,5702,6022,4072,0331,094553418
Cost of Goods Sold Incl. D&A659772751760744650391184129
Gross Profit1,8301,7581,8181,8421,6631,382703369289
Selling, General and Administrative Excl. Other1,0321,0851,3461,3671,3011,105887339265
Research and Development2712783073493343121656554
Other Operating Expense7016581,18637513,6812311584541
Operating Income-174-263-1,021-249-13,653-266-506-80-71
Interest Expense202024222281602926
Unusual Expense
—————————
Non-Operating Income (Expense)1047515112-38-1000
Net Income Before Taxes-183-236-994-220-13,663-385-576-109-97
Income Taxes-5-3581-444-91-110
Consolidated Net Income-178-200-1,001-220-13,660-429-485-99-97
Net Income From Continuing Operations-178-200-1,001-220-13,660-429-485-99-97
Net Income-178-200-1,001-220-13,660-429-485-99-97
EPS (Recurring)-0.99-1.14-5.87-1.36-84.60-2.73-5.36-1.38-1.47
EPS (Basic, Before Extraordinaries)-0.99-1.14-5.87-1.36-84.60-2.73-5.36-1.38-1.47
EPS (Diluted)-0.99-1.14-5.87-1.34-84.60-2.73-5.36-1.38-1.47
EBITDA-701473244-8-31-354-35-30
Other After Tax Adjustments
—————————
Stock Option Compensation Expense
—————————
Price To Earnings Ratio
—————————
Price To Sales Ratio0.490.490.601.341.587.0916.6310.907.83
Gross Margin73.5269.4970.7470.7969.0967.9864.2666.7369.14
Operating Margin-6.99-10.40-39.73-9.57-567.22-13.08-46.25-14.47-16.99
Net Margin-7.15-7.91-38.95-8.46-567.51-21.10-44.33-17.90-23.21
Shares Outstanding180176171162161157917266
Market Capitalization1,2081,2321,5543,4913,80814,41618,1966,0283,272
Operating Lease Expense
—————————
Unlock full historical data
See years of past statements with Premium.
Unlock with Premium
Insider Trading Volume
$10.51$8.80$7.09$5.39$3.68● Close Price0.00K172.65K345.30K517.94K690.59KUSD Trades VolumeAugSepOctNovDec2026FebMarAprMayJunJulAug
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
Bliss KellyPresident, U.S. Group HealthJul 06 '26Sale9.502,50023,75084,878Jul 06
Catapano Joseph RonaldChief Accounting OfficerJul 02 '26Sale9.106535,94212,267Jul 06
Catapano Joseph RonaldChief Accounting OfficerJul 01 '26Option Exercise0.002,083012,920Jul 06
Bliss KellyPresident, U.S. Group HealthJul 01 '26Sale9.002,50022,50087,378Jul 01
Bliss KellyPresident, U.S. Group HealthJun 29 '26Sale8.502,50021,25089,878Jun 30
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERJun 11 '26Sale6.9418,074125,470414,622Jun 12
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERJun 10 '26Option Exercise0.0042,8020432,696Jun 12
Rodrigues Fernando M.President of BetterHelpJun 03 '26Sale7.409,57270,8330Jun 04
SNOW DAVID B JRDirectorMay 20 '26Option Exercise0.0028,9860113,032May 21
SHEDLARZ DAVID LDirectorMay 20 '26Option Exercise0.0058,972061,266May 21
Jacobson CatherineDirectorMay 20 '26Option Exercise0.0028,986066,853May 21
Catapano Joseph RonaldChief Accounting OfficerApr 02 '26Sale5.116753,45210,249Apr 03
Catapano Joseph RonaldChief Accounting OfficerApr 01 '26Option Exercise0.002,083010,924Apr 03
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERMar 11 '26Sale5.4927,731152,243364,784Mar 12
DIVITA CHARLES IIICHIEF EXECUTIVE OFFICERMar 10 '26Option Exercise0.0064,6530392,515Mar 12
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR
QuoTrend signals describe historical patterns and statistics — educational information, not investment advice or a recommendation to buy or sell. Past performance doesn’t guarantee future results. Every figure traces to QuoTrend data. Historical patterns — not a prediction or advice.